Literature DB >> 25711289

Exposure to non-steroid anti-inflammatory drugs (NSAIDs) and suppressing hydrogen sulfide synthesis leads to altered structure and impaired function of the oesophagus and oesophagogastric junction.

Oksana Zayachkivska1, Nazar Bula, Dzvinka Khyrivska, Elena Gavrilyuk, John L Wallace.   

Abstract

INTRODUCTION: The non-steroid anti-inflammatory drugs (NSAIDs) are among the drugs that can commonly cause injury in the esophagus, such as non-reflux oesophagitis, with important clinical consequences. This injury may be 'silent' and therefore often overlooked. Recently, we established that hydrogen sulfide (H2S) is a critical mediator of esophageal mucosal protection and repair. The aim of the study was to determine the effect of naproxen, the most commonly used NSAIDs, on the oesophagus and oesophagogastric junction and its relation with suppression or stimulation of endogenous H2S synthesis during naproxen-induced oesophageal injury.
METHODS: Rats were treated with vehicle (control) or naproxen, with or without being subjected to water immersion restricted stress (Takagi et al. Chem Pharm Bul 12:465-472, 1964). Subgroups of rats were pre-treated with an inhibitor of H2S synthesis cystathionine γ-lyase (CSE) or cystathionine β-synthase (CBS), or with the Sodium sulphide (NaHS), which spontaneously generates H2S in solution. Damage of the oesophageal mucosa and oesophagogastric junction was estimated and scored using a histological damage index.
RESULTS: Treatment with naproxen increased the thickness of the corneal and epithelial layers of the oesophagus, as well as producing disorganization of the muscle plate and irregular submucosal oedema. Both injury factors, stress and suppression of H2S synthesis resulted in the development of severe esophagitis and damage to the oesophagogastric junction. The damage was exacerbated by inhibitors of H2S biosynthesis, and attenuated by treatment with NaHS.
CONCLUSIONS: Inhibition of endogenous H2S synthesis provides a novel experimental model that can be useful in preclinical studies NSAID-related non-reflux oesophagitis. H2S contributes significantly to mucosal defence in the oesophagus.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25711289     DOI: 10.1007/s10787-015-0230-7

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  37 in total

1.  STUDIES ON THE DRUGS FOR PEPTIC ULCER. A RELIABLE METHOD FOR PRODUCING STRESS ULCER IN RATS.

Authors:  K TAKAGI; Y KASUYA; K WATANABE
Journal:  Chem Pharm Bull (Tokyo)       Date:  1964-04       Impact factor: 1.645

Review 2.  Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.

Authors:  John L Wallace; Rory W Blackler; Melissa V Chan; Gabriela J Da Silva; Wagdi Elsheikh; Kyle L Flannigan; Iulia Gamaniek; Anna Manko; Lu Wang; Jean-Paul Motta; Andre G Buret
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

Review 3.  NSAID-gastroenteropathy: new aspects of pathogenesis and prevention.

Authors:  Rory W Blackler; Burcu Gemici; Anna Manko; John L Wallace
Journal:  Curr Opin Pharmacol       Date:  2014-06-13       Impact factor: 5.547

4.  Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.

Authors:  F Hvid-Jensen; L Pedersen; P Funch-Jensen; A M Drewes
Journal:  Aliment Pharmacol Ther       Date:  2014-03-11       Impact factor: 8.171

Review 5.  Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine.

Authors:  Wojciech Marlicz; Igor Loniewski; David S Grimes; Eamonn M Quigley
Journal:  Mayo Clin Proc       Date:  2014-10-29       Impact factor: 7.616

6.  Pill-induced esophageal injury: endoscopic features and clinical outcomes.

Authors:  S Abid; K Mumtaz; W Jafri; S Hamid; Z Abbas; H A Shah; A H Khan
Journal:  Endoscopy       Date:  2005-08       Impact factor: 10.093

Review 7.  Non-reflux esophagitis: a review of inflammatory diseases of the esophagus exclusive of reflux esophagitis.

Authors:  Salwan J Almashat; Lei Duan; Jeffrey D Goldsmith
Journal:  Semin Diagn Pathol       Date:  2014-02-12       Impact factor: 3.464

8.  Effects of nitrosative stress and reactive oxygen-scavenging systems in esophageal physiopathy under streptozotocin-induced experimental hyperglycemia.

Authors:  O Zayachkivska; M Gzregotsky; M Ferentc; A Yaschenko; A Urbanovych
Journal:  J Physiol Pharmacol       Date:  2008-08       Impact factor: 3.011

9.  Doxycycline-induced pill esophagitis.

Authors:  A Kadayifci; M T Gulsen; M Koruk; M C Savas
Journal:  Dis Esophagus       Date:  2004       Impact factor: 3.429

Review 10.  Interdisciplinary review for correlation between the plant origin capsaicinoids, non-steroidal antiinflammatory drugs, gastrointestinal mucosal damage and prevention in animals and human beings.

Authors:  Gyula Mózsik; Tibor Past; Omar M E Abdel Salam; Mónika Kuzma; Pál Perjési
Journal:  Inflammopharmacology       Date:  2009-06-26       Impact factor: 4.473

View more
  2 in total

1.  Dysphagia after vertical sleeve gastrectomy: Evaluation of risk factors and assessment of endoscopic intervention.

Authors:  Anand Nath; Sayali Yewale; Tung Tran; John S Brebbia; Timothy R Shope; Timothy R Koch
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

2.  A novel pH-controlled hydrogen sulfide donor protects gastric mucosa from aspirin-induced injury.

Authors:  Chun-Tao Yang; Zhen-Zhen Lai; Ze-Hang Zheng; Jian-Ming Kang; Ming Xian; Rui-Yu Wang; Kun Shi; Fu-Hui Meng; Xiang Li; Li Chen; Hui Zhang
Journal:  J Cell Mol Med       Date:  2017-04-07       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.